These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12455769)

  • 1. Mechanism of complement activation during extracorporeal blood-biomaterial interaction: effects of heparin coated and uncoated surfaces.
    Kopp R; Mottaghy K; Kirschfink M
    ASAIO J; 2002; 48(6):598-605. PubMed ID: 12455769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal circulation: in vivo and in vitro analysis of complement activation by heparin-bonded surfaces.
    Kirschfink M; Kovacs B; Mottaghy K
    Circ Shock; 1993 Jul; 40(3):221-6. PubMed ID: 8348684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Ringdal MA; Videm V
    Ann Thorac Surg; 1995 Dec; 60(6):1755-61. PubMed ID: 8787476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits.
    Videm V; Mollnes TE; Garred P; Svennevig JL
    J Thorac Cardiovasc Surg; 1991 Apr; 101(4):654-60. PubMed ID: 2008104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific complement inhibition with heparin-coated extracorporeal circuits.
    te Velthuis H; Jansen PG; Hack CE; Eijsman L; Wildevuur CR
    Ann Thorac Surg; 1996 Apr; 61(4):1153-7. PubMed ID: 8607674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.
    Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Lambris JD; Videm V; Mollnes TE
    Ann Thorac Surg; 2004 Mar; 77(3):932-41. PubMed ID: 14992902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of new surface coatings for extracorporeal circulation.
    Baksaas ST; Videm V; Fosse E; Karlsen H; Pedersen T; Mollnes TE; Hagve TA; Svennevig JL
    Perfusion; 1999 Jan; 14(1):11-9. PubMed ID: 10074642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits.
    Svennevig JL; Geiran OR; Karlsen H; Pedersen T; Mollnes TE; Kongsgard U; Frøysaker T
    J Thorac Cardiovasc Surg; 1993 Sep; 106(3):466-72. PubMed ID: 8361189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Veno-venous bypass in liver transplantation: heparin-coated perfusion circuits reduce the activation of humoral defense systems in an in vitro model.
    Scholz T; Solberg R; Okkenhaug C; Videm V; Gallimore MJ; Mathisen O; Pedersen T; Mollnes TE; Bergan A; Søreide O; Klintmalm GB; Aasen AO
    Perfusion; 2001 Jul; 16(4):285-92. PubMed ID: 11486847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
    Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery.
    Olsson C; Siegbahn A; Henze A; Nilsson B; Venge P; Joachimsson PO; Thelin S
    Scand Cardiovasc J; 2000; 34(1):33-40. PubMed ID: 10816058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-coated cardiopulmonary bypass circuits: current status.
    Hsu LC
    Perfusion; 2001 Sep; 16(5):417-28. PubMed ID: 11565897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does heparin coating improve biocompatibility? A study on complement, blood cells and postoperative morbidity during cardiac surgery.
    Belboul A; al-Khaja N
    Perfusion; 1997 Nov; 12(6):385-91. PubMed ID: 9413851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assessment of heparin coatings by their binding capacities of coagulation and complement enzymes.
    Weber N; Wendel HP; Ziemer G
    J Biomater Appl; 2000 Jul; 15(1):8-22. PubMed ID: 10972157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of bypass circuit biocompatibility: comparison and combination of heparin-coated circuit and nitric oxide gas infusion.
    Hayashi Y; Sawa Y; Hirata N; Nishimura M; Ueda H; Naka Y; Yamaguchi T; Ohtake S; Matsuda H
    J Card Surg; 2002; 17(6):477-84. PubMed ID: 12643456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-coated versus non-coated surfaces for extracorporeal circulation.
    Mottaghy K; Oedekoven B; Pöppel K; Kovacs B; Kirschfink M; Bruchmüller K; Kashefi A; Geisen C
    Int J Artif Organs; 1991 Nov; 14(11):721-8. PubMed ID: 1757160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo.
    Videm V; Mollnes TE; Bergh K; Fosse E; Mohr B; Hagve TA; Aasen AO; Svennevig JL
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):803-9. PubMed ID: 10096977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit.
    Moen O; Fosse E; Bråten J; Andersson C; Høgåsen K; Mollnes TE; Venge P; Kierulf P
    Perfusion; 1996 Mar; 11(2):113-23. PubMed ID: 8740352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.